Showing results (61-70 of 282) with videos related to
Sort By:
Pageof 29
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 2005
Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging StudyGraziano Onder, Brenda W J H Penninx, Luigi Ferrucci, et al.Nutrients|July 3, 2019
The Effects of Time Restricted Feeding on Overweight, Older Adults: A Pilot StudyStephen D Anton, Stephanie A Lee, William T Donahoo, et al.Aging and Cancer|October 3, 2022
Cancer and aging: A call to actionDejana Braithwaite, Stephen Anton, Supriya Mohile, et al.Aging & Mental Health|May 26, 2020
Agreement of Minimum Data Set 3.0 depression and behavioral symptoms with clinical diagnosis in a nursing homeYu-Jung Jenny Wei, Laurence Solberg, Cheng Chen, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 15, 2007
Designing clinical trials of interventions for mobility disability: results from the lifestyle interventions and independence for elders pilot (LIFE-P) trialMark A Espeland, Thomas M Gill, Jack Guralnik, et al.Gerontology|January 28, 2006
Comorbidity and physical function: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study)Matteo Cesari, Graziano Onder, Andrea Russo, et al.Journal of the American Geriatrics Society|November 19, 2021
Unexplained anemia of aging: Etiology, health consequences, and diagnostic criteriaJack Guralnik, William Ershler, Andrew Artz, et al.Journal of the American Geriatrics Society|September 3, 2011
Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individualsSilvia Giovannini, Graziano Onder, Rosa Liperoti, et al.JAMA|May 22, 2003
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisBruce M Psaty, Thomas Lumley, Curt D Furberg, et al.American Heart Journal|February 3, 2009
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) studyMatteo Cesari, Stephen B Kritchevsky, Hal H Atkinson, et al.Pageof 29